Hypocalcaemia after intravenous bisphosphonate: read the product information first.
Breay
Shazia
S
D004164:Diphosphonates / Q000009:adverse effects* / Q000627:therapeutic use; D004348:Drug Labeling; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy; D006996:Hypocalcemia / Q000139:chemically induced*; D007093:Imidazoles / Q000627:therapeutic use; D007262:Infusions, Intravenous; D000077211:Zoledronic Acid
D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid